Outcomes for children and adolescents with cancer: challenges for the twenty-first century.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Oncology

• Publication date

  2010-05-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2009.27.0421PMID 20404250PMCID PMC2881732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.

  2014cited by this paper
• Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

  2009cited by this paper
• Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

  2009influential reference
• Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

  2009cited by this paper
• JAK mutations in high-risk childhood acute lymphoblastic leukemia

  2009influential reference
• Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.

  2009cited by this paper
• Birth weight and childhood leukemia: A meta‐analysis and review of the current evidence

  2009cited by this paper
• High-Dose Methotrexate and Early Intensification of Therapy Do Not Improve 3 Year EFS in Children and Adolescents with Disseminated Lymphoblastic Lymphoma. Results of the Randomized Arms of COG A5971

  2008cited by this paper
• Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

  2008cited by this paper
• Outcome of children less than three years old at diagnosis with non‐metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and II protocols

  2008cited by this paper
• Shortened intensified multi‐agent chemotherapy and non‐cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children’s Oncology Group

  2008cited by this paper
• What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.

  2008cited by this paper
• Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B‐cell non‐Hodgkin’s lymphoma: results of the FAB/LMB 96 international study *

  2008cited by this paper
• The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.

  2008cited by this paper
• Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.

  2008cited by this paper
• Childcare in the first 2 years of life reduces the risk of childhood acute lymphoblastic leukemia

  2008cited by this paper
• Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.

  2008cited by this paper
• Temporal trends in the incidence rate of childhood cancer in Germany 1987–2004

  2007cited by this paper
• Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—a report from the Children's Oncology Group

  2007cited by this paper
• Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.

  2007cited by this paper
• Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.

  2007cited by this paper
• The pediatric preclinical testing program: Description of models and early testing results

  2007cited by this paper
• Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

  2006cited by this paper
• Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

  2006cited by this paper
• Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.

  2006cited by this paper
• Time trends of cancer incidence in European children (1978-1997): report from the Automated Childhood Cancer Information System project.

  2006cited by this paper
• Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

  2005cited by this paper
• International Classification of Childhood Cancer, third edition

  2005cited by this paper
• Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia

  2005cited by this paper
• Ethnic Difference in Daycare Attendance, Early Infections, and Risk of Childhood Acute Lymphoblastic Leukemia

  2005cited by this paper
• Acute myeloid leukemia and Down Syndrome evolution of modern therapy—state of the art review

  2005cited by this paper
• Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study

  2005cited by this paper
• Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.

  2004cited by this paper
• Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate.

  2004influential reference
• Doxorubicin for favorable histology, Stage II–III Wilms tumor

  2004cited by this paper
• Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.

  2003cited by this paper
• Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

  2003cited by this paper
• Head start

  2003cited by this paper
• Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.

  2003cited by this paper
• All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

  2002cited by this paper
• Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351

  2001cited by this paper
• The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.

  2001cited by this paper
• Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.

  2000cited by this paper
• Permutation tests for joinpoint regression with applications to cancer rates.

  2000cited by this paper
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

  2000cited by this paper
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995

  2000cited by this paper
• Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

  1999cited by this paper
• Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.

  1998cited by this paper
• Trends in reported incidence of primary malignant brain tumors in children in the United States.

  1998cited by this paper
• Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.

  1998cited by this paper
• Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.

  1998cited by this paper
• Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group.

  1997cited by this paper
• Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study.

  1994cited by this paper
• Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group.

  1993cited by this paper
• Treatment of Wilms' tumor. Results of the third national Wilms' tumor study

  1989cited by this paper
• Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.

  1986cited by this paper
• The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

  1986cited by this paper
• Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).

  1983cited by this paper
• [Treatment of Wilms' tumor].

  1983cited by this paper
• The treatment of Wilms' Tumor: Results of the second national Wilms' Tumor study

  1981cited by this paper
• Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

  1977cited by this paper
• The treatment of Wilms' tumor. Results of the national Wilms' tumor study

  1976cited by this paper
• Treatment of Wilms' tumor.

  1951cited by this paper

• Factors Influencing Immunotherapy Response in Neuroblastoma: From Tumor Microenvironment to Combination Strategies

  2026cites this paper
• Magnetic bioactive glass-modified PMMA bone cement for osteogenesis and magnetothermal-triggered tumor ablation

  2026cites this paper
• The disparity and trend of childhood cancer burden in survival perspective: a systematic analysis for the global burden of disease 2021.

  2026cites this paper
• A Primer for Pediatric Plastic Surgeons on Pediatric Head and Neck Malignancies: Part I-Epidemiology and Overview of Common Pediatric Head and Neck Tumors.

  2026cites this paper
• The future of pediatric oncology: Comprehensive review of causes, mortality, and treatment strategies

  2026cites this paper
• Abdominal Imaging at Initial Diagnosis and Following Relapse in Children With Acute Lymphoblastic Leukaemia.

  2026cites this paper
• Treatment of infantile acute lymphoblastic leukemia, experience of a country with limited resources

  2026cites this paper
• O-GlcNAcylation expression predicts a favorable prognosis and mitigates malignant phenotypes via MYCN suppression in neuroblastoma

  2026cites this paper
• Epidemiologic trends for pediatric Hodgkin and non-Hodgkin lymphomas: a U.S. population-based study

  2025cites this paper
• Impact of Chemotherapy on Vaccine Immunogenicity and Revaccination Response of Acute Lymphoblastic Leukemia—A Systematic Review and Meta-Analysis

  2025cites this paper
• Musculoskeletal Tumor Care Disparities Prior to Initiation of Treatment Among Newly Diagnosed Adult Patients

  2025cites this paper
• Awareness and Knowledge of Chemotherapy Among Cancer Patients at Suresh Wagle Memorial Cancer Centre, Kathmandu

  2025cites this paper
• Circulating Endothelial Progenitor Cells and Metabolic Factors in Childhood Cancer Survivors

  2025cites this paper
• RAS gene polymorphisms confer the risk of neuroblastoma in Chinese children from Jiangsu province

  2025cites this paper
• Virtual classrooms, real resilience: how AI tutors enhance cognitive rehabilitation in pediatric cancer survivors.

  2025cites this paper
• Early phase study enrollment in Canadian children with cancer near end of life: A retrospective cohort study from Cancer in Young People in Canada

  2025cites this paper
• Does Joint Care Impact Teenage and Young Adult’s Patient-Reported Outcomes After a Cancer Diagnosis? Results from BRIGHTLIGHT_2021

  2025cites this paper
• Factors Associated With Rare Pediatric Cancer Trial Enrollment: A Report From the Children's Oncology Group Rare Tumors Committee

  2025cites this paper
• A Review on the Potential Effects of Curcumin in the Treatment of Neuroblastoma and its Underlying Mechanisms.

  2025cites this paper
• Visualization of the microstructure and distribution of follicles in deep human ovaries using speckle-modulated optical coherence microscopy

  2025cites this paper
• The baseline 18F-FDG PET/CT imaging features in pediatric patients with congenital neuroblastoma

  2025cites this paper
• Patterns, clinical presentations, and time to diagnosis in pediatric central nervous system tumors: insights from a pediatric neuro-oncology tumor board team at a tertiary referral hospital in Ethiopia

  2025cites this paper
• Pediatric Cancer Rehabilitation: An Overview with Special Considerations in Transitional Care for Adolescents and Young Adults and Palliative Rehabilitation.

  2025cites this paper
• Long‐Term Projections of Childhood Cancer Incidence and Prevalence in Ontario, Canada Until 2040

  2025cites this paper
• Development of a Microsimulation Model to Project the Future Prevalence of Childhood Cancer in Ontario, Canada

  2025cites this paper
• Outcomes of Adolescent LBCL Patients Treated With Adult Type Chemotherapy: A Single Center Experience.

  2025cites this paper
• Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis

  2025cites this paper
• High-throughput 3D engineered paediatric tumour models for precision medicine

  2025cites this paper
• Comparative analysis of plasma and bone marrow nutrient levels in pediatric B-ALL patients

  2025cites this paper
• Results of the Latin American Pediatric Oncology Group (GALOP) Trial for Patients With Metastatic Ewing Sarcoma: Multicentric Study of Interval‐Compressed Multiagent and Metronomic Chemotherapy

  2025cites this paper
• Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma

  2025cites this paper
• A Nomogram for Predicting Cancer-Specific Survival of Neuroblastoma in Children < 2 Years Old: A SEER Database Analysis

  2025cites this paper
• The Hungarian cross-cultural adaptation of the MMQL-AF for measuring quality of life in adolescents with cancer

  2025cites this paper
• IFN-gamma in the tumor microenvironment: dual roles in cancer progression and therapy

  2025cites this paper
• Impact of neighborhood archetypes on overall mortality among young patients with acute leukemia in California

  2025cites this paper
• Factors Associated with Bone Union Failure After Frozen Autograft Reconstruction in Lower Limb Osteosarcoma

  2025cites this paper
• Advances in Targeting Growth Factor Signalling in Neuroblastoma and Overcoming Drug Resistance

  2025cites this paper
• Management of spinal chordomas and sarcomas: WFNS spine committee recommendations

  2025cites this paper
• Results of the Latin American Pediatric Oncology Group (GALOP‐2011) Trial for Patients With Localized Ewing Sarcoma: A Multicentric Study of Interval‐Compressed Multiagent Chemotherapy

  2025cites this paper
• Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma.

  2025cites this paper
• The Role of Sociodemographics in Pediatric, Adolescent and Young Adult Osteosarcoma: A Population Based Study.

  2025cites this paper
• How Classmates Experience Visiting Their Hospitalised Peer During Cancer Treatment: A RESPECT Study

  2025cites this paper
• Prevalence and Risk Factors of Chemotherapy-Induced Oral Mucositis in 470 Children With Acute Lymphoblastic Leukemia.

  2025cites this paper
• The emerging role of miR-362 in cancer: expression and function across different cancer types

  2025cites this paper
• Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review

  2024cites this paper
• Data‐driven discovery of gene expression markers distinguishing pediatric acute lymphoblastic leukemia subtypes

  2024cites this paper
• Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index

  2024cites this paper
• Impact of electronic cigarettes on pediatric, adolescent and young adult leukemia patients

  2024cites this paper
• An update on oncofertility in prepubertal females.

  2024cites this paper
• Ct-based intratumoral and peritumoral radiomics for predicting prognosis in osteosarcoma: A multicenter study.

  2024cites this paper
• Neuroblastoma differentiation type diagnosis algorithm based on Dense-U-Net using whole slide images

  2024cites this paper
• Exploring Sex-Based Neuropsychological Outcomes in Pediatric Brain Cancer Survivors: A Pilot Study

  2024cites this paper
• CGREF1 modulates osteosarcoma proliferation by regulating the cell cycle through the Wnt/β-catenin signaling pathway

  2024cites this paper
• Accelerating pediatric hodgkin lymphoma research: the hodgkin lymphoma data collaboration (NODAL).

  2024cites this paper
• Global, regional, and national epidemiology of childhood neuroblastoma (1990–2021): a statistical analysis of incidence, mortality, and DALYs

  2024cites this paper
• The Research Progress of WD Protein Subfamily in Tumor Mechanism

  2024cites this paper
• SAP30, a novel autophagy regulatory gene in neuroblastoma

  2024cites this paper
• Inhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis

  2024cites this paper
• Late oral adverse effects of chemotherapy for hematological malignancies in children: A systematic review and meta-analysis of case-control studies.

  2024cites this paper
• Machine Learning–based Prediction of Blood Stream Infection in Pediatric Febrile Neutropenia

  2024cites this paper
• Ewing Sarcoma in the Pediatric Population: Predictors of Survival Within the United States

  2024cites this paper
• Evaluation of Socioeconomic and Racial/Ethnic Disparities in All-Cause Mortality in Adolescents and Young Adults With Cancer.

  2024cites this paper
• Navigating the Diagnostic Dilemma of Hodgkin Lymphoma in Adolescents: A Primary Care Perspective

  2024cites this paper
• Online Ambassador Visits for Hospitalized Children With Cancer: Qualitative Evaluation of Implementation

  2024cites this paper
• A single-cell and spatially resolved atlas of human osteosarcomas

  2024cites this paper
• Safety and outcome of children, adolescents and young adults participating in phase I/II clinical oncology trials: a 9-year center experience

  2024cites this paper
• DICER1 rs3742330 and AGO1 rs636832 polymorphisms and acute lymphoblastic leukemia in Greek children and adolescents: A case-control study

  2024cites this paper
• The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma

  2024cites this paper
• Survival trend and outcome prediction for pediatric Hodgkin and non-Hodgkin lymphomas based on machine learning

  2024cites this paper
• Benefits for children with suspected cancer from routine whole-genome sequencing

  2024cites this paper
• Dickopff 1 inhibits cancer stem cell properties and promotes neuronal differentiation of human neuroblastoma cell line SH-SY5Y

  2024cites this paper
• Exploring the lived experience of mothers of children with leukemia: a qualitative study from Iran

  2024cites this paper
• Effect of AMH on primordial follicle populations in mouse ovaries and human pre-pubertal ovarian xenografts during doxorubicin treatment

  2024cites this paper
• Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia

  2024cites this paper
• Event Free Survival and Overall Survival in Adolescents with Acute Lymphoblastic Leukemia: A Retrospective Review

  2024cites this paper
• A useful mTORC1 signaling-related RiskScore model for the personalized treatment of osteosarcoma patients by using the bulk RNA-seq analysis

  2024cites this paper
• Plumbagin induces G2/M arrest and apoptosis and ferroptosis via ROS/p38 MAPK pathway in human osteosarcoma cells

  2024cites this paper
• Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma

  2024cites this paper
• Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers

  2024cites this paper
• Fate control engagement augments NK cell responses in LV/hu-IL-12 transduced sarcoma.

  2024cites this paper
• Model of micro-metastases of breast cancer cells in ovarian tissue: cryopreservation of ZR-75-1 and MDA-MB-231 cells with increased speed of warming increases malignancy.

  2024cites this paper
• Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade

  2024cites this paper
• Pediatric Upper Abdominal Masses: Current Practical Imaging Assessment.

  2024cites this paper
• Exploration of the intracellular chiral metabolome in pediatric BCP-ALL: a pilot study investigating the metabolic phenotype of IgH locus aberrations

  2024cites this paper
• Educational outcomes school year nine in children treated for acute lymphoblastic leukemia: A nationwide registry‐based study from Sweden

  2024cites this paper
• Trends in Pediatric Cancer Care in Florida From 1981-2020: Changing Patterns in a Growing and Increasingly Diverse Population

  2023cites this paper
• Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview

  2023cites this paper
• Innovations in Cancer Treatment of Children

  2023cites this paper
• PPARβ/δ-ANGPTL4 axis mediates the promotion of mono-2-ethylhexyl phthalic acid on MYCN-amplified neuroblastoma development.

  2023cites this paper
• Factors That Influence Physical Activity Behavior in Children and Adolescents During and After Cancer Treatment: A Qualitative Systematic Review of the Literature.

  2023cites this paper
• Finding Integrative Medication for Neuroblastoma and Glioblastoma through Zebrafish as A Model of Organism.

  2023cites this paper
• Patterns of physical activity and sedentary behavior in child and adolescent cancer survivors assessed using wrist accelerometry: A cluster analysis approach

  2023cites this paper
• Longitudinal assessment of Leydig cell function in male survivors of childhood cancer

  2023cites this paper
• A multiparameter diagnostic model based on 2-[18F]FDG PET/CT metabolic parameters and clinical variables can differentiate high-risk and non-high-risk pediatric neuroblastoma under the revised Children’s Oncology Group classification system

  2023cites this paper
• The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma

  2023cites this paper
• Outlooks on using a mobile health intervention for supportive pain management for children and adolescents with cancer: a qualitative study

  2023cites this paper
• Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities

  2023cites this paper
• Kirurško liječenje bolesti štitnjače u pedijatrijskoj populaciji

  2023cites this paper
• Fifty years of DIPG: looking at the future with hope

  2023cites this paper
• Cisplatin triggers oxidative stress, apoptosis and pro‐inflammatory responses by inhibiting the SIRT1‐mediated Nrf2 pathway in chondrocytes

  2023cites this paper